ESSA Pharma IncNASDAQ:EPIX
- LAST PRICE5.4600
- TODAY'S CHANGE (%)-0.0300 (-0.5464%)
- Bid / Lots5.1300/ 1
- Ask / Lots5.4500/ 21
- Open / Previous Close5.5200 / 5.4900
- Day Range
- 52 Week Range
- Volume34,117
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EPIX |
|---|---|---|
| 09:32 ET | 136 | 5.52 |
| 09:33 ET | 3200 | 5.54 |
| 09:35 ET | 300 | 5.1882 |
| 09:42 ET | 1200 | 5.43 |
| 09:44 ET | 2300 | 5.36 |
| 09:46 ET | 200 | 5.265 |
| 09:53 ET | 127 | 5.15 |
| 10:04 ET | 200 | 5.21 |
| 10:08 ET | 300 | 5.26 |
| 10:09 ET | 100 | 5.28 |
| 10:22 ET | 397 | 5.221 |
| 10:45 ET | 200 | 5.36 |
| 10:47 ET | 1301 | 5.35 |
| 11:02 ET | 436 | 5.38 |
| 11:05 ET | 300 | 5.41 |
| 11:23 ET | 470 | 5.45 |
| 11:38 ET | 440 | 5.44 |
| 11:52 ET | 100 | 5.375 |
| 12:01 ET | 100 | 5.45 |
| 12:37 ET | 500 | 5.45 |
| 12:44 ET | 247 | 5.45 |
| 01:04 ET | 200 | 5.41 |
| 01:08 ET | 102 | 5.41 |
| 01:26 ET | 974 | 5.47 |
| 01:27 ET | 600 | 5.49 |
| 01:54 ET | 5900 | 5.49 |
| 02:02 ET | 100 | 5.43 |
| 02:07 ET | 200 | 5.465 |
| 02:14 ET | 300 | 5.44 |
| 02:16 ET | 600 | 5.44 |
| 02:27 ET | 200 | 5.44 |
| 02:36 ET | 200 | 5.44 |
| 02:48 ET | 200 | 5.44 |
| 02:57 ET | 100 | 5.44 |
| 03:03 ET | 300 | 5.44 |
| 03:24 ET | 100 | 5.44 |
| 03:30 ET | 2111 | 5.465 |
| 03:42 ET | 800 | 5.47 |
| 03:46 ET | 850 | 5.47 |
| 03:48 ET | 100 | 5.425 |
| 03:50 ET | 800 | 5.425 |
| 03:55 ET | 500 | 5.376 |
| 03:57 ET | 100 | 5.37 |
| 04:00 ET | 300 | 5.46 |
Nov 21, 2023
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference, from 8:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
8:00AM ET on Tuesday Nov 21, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ESSA Pharma Inc | 242.1M | -8.8x | --- |
Inozyme Pharma Inc | 242.7M | -2.6x | --- |
Gossamer Bio Inc | 243.4M | -0.6x | --- |
Atea Pharmaceuticals Inc | 245.3M | -1.9x | --- |
Immuneering Corp | 239.1M | -3.9x | --- |
Ovid Therapeutics Inc | 241.0M | -4.9x | --- |
Company Information
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.
Contact Information
- Headquarters
- Suite 2600, 595 Burrard StreetVANCOUVER, BC, Canada V5Z 1K5
- Phone
- 778-331-0962
- Fax
- 778-331-0962
Executives
- Non-Executive Independent Chairman of the Board
- Richard Glickman
- President, Chief Executive Officer, Director
- David Parkinson
- Chief Financial Officer
- David Wood
- Chief Operating Officer, Executive Vice President
- Peter Virsik
- Chief Medical Officer
- Alessandra Cesano
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $242.1M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 44.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.88 |
EPS | $-0.62 |
Book Value | $3.79 |
P/E Ratio | -8.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
